FVIII muteins for treatment of von Willebrand disease

Details for Australian Patent Application No. 2009256093 (hide)

Owner Bayer HealthCare LLC

Inventors Liu, Tongyao; Pan, Junliang; Jiang, Haiyan; Zhang, Xin; Pierce, Glenn; Murphy, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2009256093

PCT Pub. Number WO2009/149303

Priority 61/058,795 04.06.08 US

Filing date 4 June 2009

Wipo publication date 10 December 2009

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2009/149303 Priority application(s): WO2009/149303

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256100-Method and apparatus for cooling solid particles under high temperature and pressure

2009256088-Upgraded combustion ash and its method of production